BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 29268817)

  • 1. MYBL2 Is Targeted by miR-143-3p and Regulates Breast Cancer Cell Proliferation and Apoptosis.
    Chen J; Chen X
    Oncol Res; 2018 Jul; 26(6):913-922. PubMed ID: 29268817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA LOXL1-AS1 regulates the tumorigenesis and development of lung adenocarcinoma through sponging miR-423-5p and targeting MYBL2.
    Li W; Zhang B; Jia Y; Shi H; Wang H; Guo Q; Li H
    Cancer Med; 2020 Jan; 9(2):689-699. PubMed ID: 31758653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. lncRNA RPSAP52 induced the development of tongue squamous cell carcinomas via miR-423-5p/MYBL2.
    Wu X; Gong Z; Ma L; Wang Q
    J Cell Mol Med; 2021 May; 25(10):4744-4752. PubMed ID: 33787061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of GSK3B by miR-132-3p Enhances Etoposide-Induced Breast Cancer Cell Apoptosis.
    Xu C; Du Z; Ren S; Pian Y
    Ann Clin Lab Sci; 2021 May; 51(3):285-294. PubMed ID: 34162557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of MYBL2 promotes proliferation and migration of non-small-cell lung cancer via upregulating NCAPH.
    Xiong YC; Wang J; Cheng Y; Zhang XY; Ye XQ
    Mol Cell Biochem; 2020 May; 468(1-2):185-193. PubMed ID: 32200471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actin-binding Rho activating C-terminal like (ABRACL) transcriptionally regulated by MYB proto-oncogene like 2 (MYBL2) promotes the proliferation, invasion, migration and epithelial-mesenchymal transition of breast cancer cells.
    Li J; Chen H
    Bioengineered; 2022 Apr; 13(4):9019-9031. PubMed ID: 35341461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of MYBL2 predicts poor prognosis and promotes oncogenesis in endometrial carcinoma.
    Le L; Luo J; Wu H; Chen L; Tang X; Fu F
    Eur J Histochem; 2021 Mar; 65(2):. PubMed ID: 33782625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-205-3p promotes proliferation and reduces apoptosis of breast cancer MCF-7 cells and is associated with poor prognosis of breast cancer patients.
    Qiu C; Huang F; Zhang Q; Chen W; Zhang H
    J Clin Lab Anal; 2019 Oct; 33(8):e22966. PubMed ID: 31578772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-30b-5p inhibits proliferation and promotes apoptosis of medulloblastoma cells via targeting MYB proto-oncogene like 2 (MYBL2).
    Xu C; He Z; Lin C; Shen Z
    J Investig Med; 2020 Aug; 68(6):1179-1185. PubMed ID: 32690599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-142-3p targets HMGA2 and suppresses breast cancer malignancy.
    Mansoori B; Duijf PHG; Mohammadi A; Safarzadeh E; Ditzel HJ; Gjerstorff MF; Cho WC; Baradaran B
    Life Sci; 2021 Jul; 276():119431. PubMed ID: 33785332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATF-3/miR-590/GOLPH3 signaling pathway regulates proliferation of breast cancer.
    Song Q; Chen Q; Wang Q; Yang L; Lv D; Jin G; Liu J; Li B; Fei X
    BMC Cancer; 2018 Mar; 18(1):255. PubMed ID: 29534690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of MYB proto-oncogene like 2 in tamoxifen resistance in breast cancer.
    Li X; Zhang X; Wu CC; Li PP; Fu YM; Xie LH; Sun SS; Zhou YY; Zhu BL
    J Mol Histol; 2021 Feb; 52(1):21-30. PubMed ID: 33141360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDAC3 increases HMGB3 expression to facilitate the immune escape of breast cancer cells via down-regulating microRNA-130a-3p.
    Chen Z; Pei L; Zhang D; Xu F; Zhou E; Chen X
    Int J Biochem Cell Biol; 2021 Jun; 135():105967. PubMed ID: 33727043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA hsa_circ_0000376 Participates in Tumorigenesis of Breast Cancer by Targeting miR-1285-3p.
    Peng Z; Xu B; Jin F
    Technol Cancer Res Treat; 2020; 19():1533033820928471. PubMed ID: 32462972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of MiR-1908-3p as a novel serum biomarker for breast cancer and analysis its oncogenic function and target genes.
    Zhu Y; Wang Q; Xia Y; Xiong X; Weng S; Ni H; Ye Y; Chen L; Lin J; Chen Y; Niu H; Chen X; Lin Y
    BMC Cancer; 2020 Jul; 20(1):644. PubMed ID: 32650755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamate metabotropic receptor 4 (GRM4) inhibits cell proliferation, migration and invasion in breast cancer and is regulated by miR-328-3p and miR-370-3p.
    Xiao B; Chen D; Zhou Q; Hang J; Zhang W; Kuang Z; Sun Z; Li L
    BMC Cancer; 2019 Sep; 19(1):891. PubMed ID: 31492116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-519d-3p Inhibits Proliferation and Promotes Apoptosis by Targeting HIF-2Ī± in Cervical Cancer Under Hypoxic Conditions.
    Jiang L; Shi S; Shi Q; Zhang H; Xia Y; Zhong T
    Oncol Res; 2018 Aug; 26(7):1055-1062. PubMed ID: 29321085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demethylzeylasteral inhibits glioma growth by regulating the miR-30e-5p/MYBL2 axis.
    Zhang K; Fu G; Pan G; Li C; Shen L; Hu R; Zhu S; Chen Y; Cui H
    Cell Death Dis; 2018 Oct; 9(10):1035. PubMed ID: 30305611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-129-3p promotes docetaxel resistance of breast cancer cells via CP110 inhibition.
    Zhang Y; Wang Y; Wei Y; Li M; Yu S; Ye M; Zhang H; Chen S; Liu W; Zhang J
    Sci Rep; 2015 Oct; 5():15424. PubMed ID: 26487539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-548d-3p/TP53BP2 axis regulates the proliferation andĀ apoptosis of breast cancer cells.
    Song Q; Song J; Wang Q; Ma Y; Sun N; Ma J; Chen Q; Xia G; Huo Y; Yang L; Li B
    Cancer Med; 2016 Feb; 5(2):315-24. PubMed ID: 26663100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.